Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
Survival in patients with unresectable pancreatic carcinoma is poor. Studies by Mayo Clinic and the Gastrointestinal Tumor Study Group (GITSG) have established combined modality treatment with chemotherapy and radiation as the standard of care. Use of gemcitabine-based chemotherapy alone has also be...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2010-08-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2072-6694/2/3/1565/ |
| _version_ | 1797720995028533248 |
|---|---|
| author | Robert C. Miller Michael C. Stauder |
| author_facet | Robert C. Miller Michael C. Stauder |
| author_sort | Robert C. Miller |
| collection | DOAJ |
| description | Survival in patients with unresectable pancreatic carcinoma is poor. Studies by Mayo Clinic and the Gastrointestinal Tumor Study Group (GITSG) have established combined modality treatment with chemotherapy and radiation as the standard of care. Use of gemcitabine-based chemotherapy alone has also been shown to provide a benefit, but 5‑year overall survival still remains less than 5%. Conventional radiotherapy is traditionally delivered over a six week period and high toxicity is seen with the concomitant use of chemotherapy. In contrast, SBRT can be delivered in 3–5 days and, when used as a component of combined modality therapy with gemcitabine, disruption to the timely delivery of chemotherapy is minimal. Early single-institution reports of SBRT for unresectable pancreatic carcinoma demonstrate excellent local control with acceptable toxicity. Use of SBRT in unresectable pancreatic carcinoma warrants further investigation in order to improve the survival of patients with historically poor outcomes. |
| first_indexed | 2024-03-12T09:28:30Z |
| format | Article |
| id | doaj.art-98081b87dffe417dabf9b27813e1f105 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-12T09:28:30Z |
| publishDate | 2010-08-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-98081b87dffe417dabf9b27813e1f1052023-09-02T14:02:50ZengMDPI AGCancers2072-66942010-08-01231565157510.3390/cancers2031565Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic CarcinomaRobert C. MillerMichael C. StauderSurvival in patients with unresectable pancreatic carcinoma is poor. Studies by Mayo Clinic and the Gastrointestinal Tumor Study Group (GITSG) have established combined modality treatment with chemotherapy and radiation as the standard of care. Use of gemcitabine-based chemotherapy alone has also been shown to provide a benefit, but 5‑year overall survival still remains less than 5%. Conventional radiotherapy is traditionally delivered over a six week period and high toxicity is seen with the concomitant use of chemotherapy. In contrast, SBRT can be delivered in 3–5 days and, when used as a component of combined modality therapy with gemcitabine, disruption to the timely delivery of chemotherapy is minimal. Early single-institution reports of SBRT for unresectable pancreatic carcinoma demonstrate excellent local control with acceptable toxicity. Use of SBRT in unresectable pancreatic carcinoma warrants further investigation in order to improve the survival of patients with historically poor outcomes.http://www.mdpi.com/2072-6694/2/3/1565/stereotactic radiotherapyradiotherapypancreatic neoplasms |
| spellingShingle | Robert C. Miller Michael C. Stauder Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma Cancers stereotactic radiotherapy radiotherapy pancreatic neoplasms |
| title | Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma |
| title_full | Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma |
| title_fullStr | Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma |
| title_full_unstemmed | Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma |
| title_short | Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma |
| title_sort | stereotactic body radiation therapy sbrt for unresectable pancreatic carcinoma |
| topic | stereotactic radiotherapy radiotherapy pancreatic neoplasms |
| url | http://www.mdpi.com/2072-6694/2/3/1565/ |
| work_keys_str_mv | AT robertcmiller stereotacticbodyradiationtherapysbrtforunresectablepancreaticcarcinoma AT michaelcstauder stereotacticbodyradiationtherapysbrtforunresectablepancreaticcarcinoma |